Member Publications

• Journal articles
• Chapters
• Other
• Preprints

Journal articles

• Gibson FG, Paggiosi MA, Handforth C, Brown JE, Li X, Dall'Ara E & Verbruggen SW (2025) Altered vertebral biomechanical properties in prostate cancer patients following androgen deprivation therapy. Bone, 195, 117465-117465.
• Henyš P, Dall’Ara E & Martelli S (2025) Symmetric normalization algorithm for estimating physiological strain in bones. European Journal of Mechanics - A/Solids, 111, 105539-105539.
• Nüesch A, Ferri MP & Le Maitre CL (2025) Application and validation of semiautomatic quantification of immunohistochemically stained sections for low cellular tissue such as intervertebral disc using QuPath. JOR Spine, 8(1). View this article in WRRO
• Shalof H, Chong RS, Rigby A & Offiah AC (2025) In children under two years of age, does the bone health index value differ between those with and without osteogenesis imperfecta?. Bone, 117467-117467.
• Hodgson AKO, Baxandall L, Aiyedun D, Li A, Au PYB, Bain JM, Gillentine MA, Goel H, Kline AD, Ricupero CL , Sánchez-Carpintero R et al (2025) Expanding the Phenotypic Spectrum of HNRNPU-Related Disorder, Documenting the First Familial Presentation and Comprehensive Review.. Am J Med Genet A, e64013.
• Jaalkhorol M, Johansson H, Avirmed S, Dashtseren A, Bruyère O, Lorentzon M, Harvey NC, McCloskey EV & Kanis JA (2025) A surrogate FRAX model for Mongolia. Archives of Osteoporosis, 20(1), 27.
• Bermudez-Lekerika P, Tseranidou S, Kanelis E, Nüesch A, Crump KB, Alexopoulos LG, Wuertz-Kozak K, Noailly J, Le Maitre CL & Gantenbein B (2025) Ex Vivo and In Vitro Proteomic Approach to Elucidate the Relevance of IL-4 and IL-10 in Intervertebral Disc Pathophysiology.. JOR Spine, 8(1), e70048.
• Pagnamenta AT, Hashim M, Kennedy J, Lawton B, Offiah AC, Taylor JC & Smithson SF (2025) A Cryptic CBFB Deletion–Inversion Expands the Mutational Spectrum of Variants Associated With Cleidocranial Dysplasia. Clinical Genetics.
• van Maanen JC, Bach FC, Snuggs JW, Ito K, Wauben MHM, Le Maitre CL & Tryfonidou MA (2025) Explorative Study of Modulatory Effects of Notochordal Cell‐Derived Extracellular Vesicles on the IL‐1β‐Induced Catabolic Cascade in Nucleus Pulposus Cell Pellets and Explants. JOR SPINE, 8(1).
• Song K, Vijjhalwar R, Aye M, Comninos AN, Schini M, Abbas A, Gittoes N & Javaid MK (2025) Assessing and Managing Primary Hyperparathyroidism and Fracture Risk in England: A Survey of Medical Professionals. Journal of the Endocrine Society, 9(2).
• Paddock M, Bains PS, Kvist O, Andronikou S, Franchi-Abella S, van Rijn RR, Arthurs OJ & Offiah AC (2025) The publication fate of abstracts awarded prizes at European Society of Paediatric Radiology annual scientific meetings. Pediatric Radiology.
• Eastell R, Brown JP, Adler RA, Lewiecki EM, Binkley N, Orwoll ES, Kendler D, Mitlak BH & Wang Y (2025) Bone Turnover Markers Predict Changes in Bone Mineral Density in Men Treated with Abaloparatide: Results from ATOM.. J Bone Miner Res.
• Tan ATH, Johansson H, Harvey NC, Lorentzon M, Kanis JA, McCloskey E & Schini M (2025) Assessment of fracture risk with FRAX and FRAXplus. Gaceta Médica de México, 160(4).
• Cavazzoni G, Pasini M, Le Maitre CL, Dall'Ara E & Palanca M (2025) Degeneration of the nucleus pulposus affects the internal volumetric strains and failure location of adjacent human metastatic vertebral bodies. Acta Biomaterialia.
• Evans S & Offiah A (2025) Which paediatric fractures lack research evidence regarding their diagnosis using artificial intelligence? A systematic review. The Royal College of Radiologists Open, 3, 100165-100165.
• Evans S, Oderinlo D, Jones D & Offiah A (2025) Assessing the performance of a deep learning algorithm for detection of scaphoid fractures in paediatric radiographs. The Royal College of Radiologists Open, 3, 100202-100202.
• Gharibzadeh S, Routen A, Razieh C, Zaccardi F, Lawson C, Gillies C, Heller S, Davies M, Atkins H, Bain SC , Lone NL et al (2025) Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study. eClinicalMedicine, 79. View this article in WRRO
• Chung Y-S, Langdahl B, Plebanski R, Czerwinski E, Dokoupilova E, Supronik J, Rosa J, Mydlak A, Sapula R, Rowińska-Osuch A , Baek K-H et al (2025) SB16 versus reference denosumab in postmenopausal women with osteoporosis: 18-month outcomes of a phase III randomized clinical trial. Bone, 192, 117371-117371.
• Steijvers E, Shi Y, Lu H, Zhang W, Zhang Y, Zhao F, Wang B, Hughes L, Barralet JE, Degli-Alessandrini G , Kraev I et al (2025) Rapid assessment of the osteogenic capacity of hydroxyapatite/aragonite using a murine tibial periosteal ossification model. Bioactive Materials, 45, 257-273.
• Cavazzoni G, Dall’Ara E & Palanca M (2024) Microstructure of the human metastatic vertebral body. Frontiers in Endocrinology, 15, 1508504.
• Elkhateeb N, Crookes R, Spiller M, Pavinato L, Palermo F, Brusco A, Parker M, Park S-M, Mendes AC, Saraiva JM , Hammer TB et al (2024) Expanding the phenotype and genotype spectrum of TAOK1 neurodevelopmental disorder and delineating TAOK2 neurodevelopmental disorder. Genetics in Medicine, 101348-101348.
• Puppo M, Croset M, Ceresa D, Valluru MK, Canuas Landero VG, Hernandez Guadarrama M, Iuliani M, Pantano F, Dawn Ottewell P & Clézardin P (2024) Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis. Breast Cancer Research, 26. View this article in WRRO
• Coleman R (2024) Out with the old (not so!) and in with the new. Journal of Bone Oncology, 100658-100658.
• Srisuwarn P, Eastell R & Salam S (2024) Clinical Utility of Bone Turnover Markers in Chronic Kidney Disease. Journal of Bone Metabolism, 31(4), 264-278.
• Wali R, Miller C, Harrison C, Stafford G & Hatton P (2024) NANOSCALE ZINC-SUBSTITUTED HYDROXYAPATITE: A BONE GRAFTING BIOMATERIAL WITH ENHANCED ANTIBACTERIAL PROPERTIES. Orthopaedic Proceedings, 106-B(SUPP_19), 9-9.
• Boyce S, Nichol T, Smith T & Le Maitre C (2024) PREVENTING PERIPROSTHETIC JOINT INFECTION: A NOVEL ANTIMICROBIAL SOL-GEL APPROACH. Orthopaedic Proceedings, 106-B(SUPP_19), 28-28.
• Giunti G, Michelis F, Halabi A, Koledova E, Harvey J & Dimitri P (2024) The Pediatric Growth Hormone Deficiency Patient Journey: Identifying Opportunities for Digital Health Interventions.
• Katsoula G, Lawrence JEG, Arruda AL, Tutino M, Balogh P, Southam L, Swift D, Behjati S, Teichmann SA, Wilkinson JM & Zeggini E (2024) Primary cartilage transcriptional signatures reflect cell-type-specific molecular pathways underpinning osteoarthritis. The American Journal of Human Genetics.
• Cristofolini L, bròdano BB, Dall’Ara E, Ferenc R, Ferguson SJ, García-Aznar JM, Lazary A, Vajkoczy P, Verlaan J-J & Vidacs L (2024) METASTRA: COMPUTER-AIDED EFFECTIVE FRACTURE RISK STRATIFICATION OF PATIENTS WITH VERTEBRAL METASTASES FOR PERSONALIZED TREATMENT THROUGH ROBUST COMPUTATIONAL MODELS VALIDATED IN CLINICAL SETTINGS. Orthopaedic Proceedings, 106-B(SUPP_18), 59-59.
• Tan ATH, Johansson H, Harvey NC, Lorentzon M, Kanis JA, McCloskey E & Schini M (2024) Evaluación del riesgo de fractura con FRAX y FRAXplus. Gaceta Médica de México, 160(4).
• Stafford-Smith B, Gurasashvili J, Peter M, Daniel M, Balasubramanian M, Bownass L, Brennan P, Cleaver R, Clowes V, Costello P , DeSouza B et al (2024) “I’m quite proud of how we’ve handled it”: health professionals’ experiences of returning additional findings from the 100,000 genomes project. European Journal of Human Genetics, 1-10.
• Shafiq T, Feng JL, Phillips L, Murias K, Ferguson M, Baranano K, Acchione A, Kipkemoi P, Kipkoech C, Chepkemoi E , Abubakar A et al (2024) An expansion of the phenotype in individuals with SYNCRIP-Related Neurodevelopmental Disorder. Rare, 2, 100052-100052.
• Briggs AH, Doyle-Connolly A, Schneider J, Podkonjak T, Taylor H, Roffe E, Low E, Davis S, Kaiser M, Hatswell AJ & Rabin N (2024) An attribution of value framework for combination treatments. Value in Health.
• Eastell R, Baumann M, Hoyle NR & Wieczorek L (2024) Discussion paper B, 141-148.
• Dimitri P, van Dommelen P, Banerjee I, Bellazzi R, Ciaccio M, de Arriba Muñoz A, Loche S, Zaini AA, Halabi A, Bagha M & Koledova E (2024) Opportunities for digitally-enabled personalization and decision support for pediatric growth hormone therapy. Frontiers in Endocrinology, 15. View this article in WRRO
• Taher MMB, Skerry TM, Cohen MC, Russell J & Offiah AC (2024) Correlation of CT measurements of total body gas volume and hounsfield units with post-mortem interval. Indian Journal of Forensic and Community Medicine, 11(3), 111-118.
• Slowik KM, Edmans JG, Harrison S, Edwards SM, Bolt R, Spain SG, Hatton PV, Murdoch C & Colley HE (2024) Controlled dual drug release from adhesive electrospun patches for prevention and treatment of alveolar osteitis. Journal of Controlled Release, 376, 253-265.
• Williamson A, Bateman L, LeMaitre C, Jones TH, Aberdein N & Kelly DM (2024) 8711 The Effect of Testosterone Therapy Upon Bone Remodelling in Testosterone Deficient APOE-/- Mice Fed a High Fat Diet. Journal of the Endocrine Society, 8(Supplement_1).
• Vilaca T, Toronjo Schini M, Thompson AR, Vittinghoff E, Lui L-Y, Ewing SK, Bauer DC, Black DM, Bouxsein M & Eastell R (2024) 7867 Treatment-related changes in total hip bone mineral density and fracture risk reduction for drugs with different mechanisms of action: the FNIH-ASBMR-SABRE project. Journal of the Endocrine Society, 8(Supplement_1). View this article in WRRO
• Brown JP, Adler RA, Lewiecki EM, Binkley N, Orwoll ES, Wang Y, Kendler DL, Mitlak BH & Eastell R (2024) 6733 Bone Turnover Markers Predict Bone Mineral Density Increases With Abaloparatide In Men Similarly To Women: Results From ATOM. Journal of the Endocrine Society, 8(Supplement_1).
• Copeland H, Low KJ, Wynn SL, Ahmed A, Arthur V, Balasubramanian M, Bennett K, Berg J, Bertoli M, Bryson L , Bucknall C et al (2024) Large-scale evaluation of outcomes after a genetic diagnosis in children with severe developmental disorders. Genetics in Medicine Open, 101864-101864.
• Cheung MS, Alves I, Carl-Inning P, Eastwood D, Magnhnie M, Offiah A, Paley D, Riganti S, Savarirayan R, Sessa M , Vogt B et al (2024) Meeting report from the 3rd ISCBH-ERN BOND Achondroplasia Workshop on Long Bone Pathology in Children with Achondroplasia, Salzburg, Austria 22nd June 2024. Bone, 117268-117268.
• Avgoustou P, Jailani ABA, Desai AJ, Roberts DJ, Lilley ER, Stothard GW, Skerry TM & Richards GO (2024) Receptor activity-modifying protein modulation of parathyroid hormone-1 receptor function and signaling. Frontiers in Pharmacology, 15. View this article in WRRO
• Moon RJ, D’ Angelo S, Curtis EM, Ward KA, Crozier SR, Schoenmakers I, Javaid MK, Bishop NJ, Godfrey KM, Cooper C , Harvey NC et al (2024) Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial. The American Journal of Clinical Nutrition.
• Colleran GC, Fossmark M, Rosendahl K, Argyropoulou M, Mankad K & Offiah AC (2024) ESR Essentials: imaging of suspected child abuse-practice recommendations by the European Society of Paediatric Radiology.. Eur Radiol.
• Vogg B, Poetzl J, Schwebig A, Sekhar S, Kivitz A, Krivtsova N, Renner O, Body J-J & Eastell R (2024) The Totality of Evidence for SDZ-deno: A Biosimilar to Reference Denosumab. Clinical Therapeutics.
• Perri G, Mathers JC, Martin-Ruiz C, Parker C, Demircan K, Chillon TS, Schomburg L, Robinson L, Stevenson EJ, Shannon OM , Muniz-Terrera G et al (2024) The association between selenium status and global and attention-specific cognition in very old adults in the Newcastle 85+ Study: cross-sectional and longitudinal analyses. The American Journal of Clinical Nutrition, S0002-9165(24)00735.
• Morita M, Arshad F, Quayle LA, George CN, Lefley DV, Kalajzic I, Balsubramanian M, Cebe T, Reilly G, Bishop NJ & Ottewell PD (2024) Losartan alters osteoblast differentiation and increases bone mass through inhibition of TGFB signalling in vitro and in an OIM mouse model. Bone Reports, 22, 101795-101795.
• Soar P, Palanca M, Dall’Ara E & Tozzi G (2024) Data-driven image mechanics (D2IM): A deep learning approach to predict displacement and strain fields from undeformed X-ray tomography images – Evaluation of bone mechanics. Extreme Mechanics Letters, 71, 102202-102202.
• Mengis T, Bernhard L, Nüesch A, Heggli I, Herger N, Devan J, Marcus R, Laux CJ, Brunner F, Farshad M , Distler O et al (2024) The expression of toll-like receptors in cartilage endplate cells: a role of toll-like receptor 2 in pro-inflammatory and pro-catabolic gene expression. Cells, 13(17). View this article in WRRO
• Gandham A, Gregori G, Johansson L, Larsson BAM, Johansson H, Harvey NC, Vandenput L, McCloskey E, Kanis JA, Litsne H , Axelsson K et al (2024) Sarcopenia definitions and their association with injurious falls in older Swedish women from the Sahlgrenska University Hospital Prospective Evaluation of Risk of Bone fractures (SUPERB) study. Osteoporosis International, 1-10.
• Al-janabi H, Moyes K, Allen R, Fisher M, Crespo M, Gurel B, Rescigno P, de Bono J, Nunns H, Bailey C , Junker-Jensen A et al (2024) Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy. Journal for ImmunoTherapy of Cancer, 12(7), e009368-e009368.
• Kreitmaier P, Swift D, Wilkinson JM & Zeggini E (2024) Epigenomic differences between osteoarthritis grades in primary cartilage. Osteoarthritis and Cartilage.
• Rosendahl K, de Horatio LT, Habre C, Shelmerdine SC, Patsch J, Kvist O, Lein RK, Plut D, Enoksen EJ, Avenarius R , Laborie LB et al (2024) The incidence of fractures in children under two years of age: a systematic review. BMC Musculoskeletal Disorders, 25(1), 528.
• Rots D, Bouman A, Yamada A, Levy M, Dingemans AJM, de Vries BBA, Ruiterkamp-Versteeg M, de Leeuw N, Ockeloen CW, Pfundt R , de Boer E et al (2024) Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome. The American Journal of Human Genetics.
• Brady S, Mott A, Carlisle K, Abhishek A, Adamson J, Coates L, van Duren B, Emery P, Goodman SM, Hewitt C , Li J et al (2024) PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) – a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study. BMJ Open, 14(6), e084997-e084997.
• Huang Q, Brown J & Mitchell C (2024) Assessment and management of fracture risk in men with prostate cancer taking androgen deprivation therapy: a retrospective observational primary care database study. British Journal of General Practice, 74(suppl 1), bjgp24X737637-bjgp24X737637.
• Handforth C, Paggiosi MA, Jacques R, Gossiel F, Eastell R, Walsh JS & Brown JE (2024) The impact of androgen deprivation therapy on bone microarchitecture in men with prostate cancer: A longitudinal observational study (The ANTELOPE Study). Journal of Bone Oncology, 47. View this article in WRRO
• Zhou J & Ottewell PD (2024) The role of IL-1B in breast cancer bone metastasis. Journal of Bone Oncology, 46, 100608-100608.
• Brown J, Santini D, Charnley N, Ogareva A, Chisholm A & Jones R (2024) Implications of bone metastasis on response to systemic therapy in patients with advanced renal cell carcinoma: A systematic literature review. Cancer Treatment Reviews, 102792-102792.
• Hodgson K, Orozco-Moreno M, Goode EA, Fisher M, Garnham R, Beatson R, Turner H, Livermore K, Zhou Y, Wilson L , Visser EA et al (2024) Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone. eBioMedicine, 104, 105163-105163.
• Hansen MS, Wölfel EM, Jeromdesella S, Møller J-JK, Ejersted C, Jørgensen NR, Eastell R, Hansen SG & Frost M (2024) Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial. eClinicalMedicine, 72, 102624-102624.
• Paddock M, Ní Leidhin C & Offiah AC (2024) Test 1, 1-48.
• Paddock M, Ní Leidhin C & Offiah AC (2024) Test 2, 49-98.
• Black DM, Thompson AR, Eastell R & Bouxsein ML (2024) Bone mineral density as a surrogate endpoint for fracture risk reduction in clinical trials of osteoporosis therapies: an update on SABRE. The Lancet Diabetes & Endocrinology.
• Bittner N, Shi C, Zhao D, Ding J, Southam L, Swift D, Kreitmaier P, Tutino M, Hankinson J, Wilkinson M , Orozco G et al (2024) OA30 Primary osteoarthritis chondrocyte map of chromatin conformation reveals novel effector genes. Rheumatology, 63(Supplement_1).
• Kistler-Fischbacher M, Armbrecht G, Gängler S, Theiler R, Rizzoli R, Dawson-Hughes B, Kanis JA, Hofbauer LC, Schimmer RC, Vellas B , Da Silva JAP et al (2024) Effects of vitamin D3, omega-3s, and a simple strength training exercise program on bone health: the DO-HEALTH randomized controlled trial. Journal of Bone and Mineral Research, 39(6), 661-671.
• Henson WH, Li X, Lin Z, Guo L, Mazzá C & Dall’Ara E (2024) Automatic segmentation of lower limb muscles from MR images of post-menopausal women based on deep learning and data augmentation. PLOS ONE, 19(4). View this article in WRRO
• Paddock M, Johnson PC, Staley A, Halliday K & Offiah AC (2024) The impact of sedation on the quality of initial skeletal surveys performed for suspected physical abuse in children: a comparative two-centre audit. Clinical Radiology.
• Kreitmaier P, Swift D, Wilkinson M & Zeggini E (2024) PROFILING METHYLATION IN PRIMARY OSTEOARTHRITIS CARTILAGE. Osteoarthritis and Cartilage, 32, S484-S484.
• Katsoula G, Lawrence JE, Tutino M, Arruda AL, Balogh P, Southam L, Swift D, Behjati S, Teichmann SA, Wilkinson M & Zeggini E (2024) The molecular environment of osteoarthritis risk genes in primary cartilage. Osteoarthritis and Cartilage, 32, S475-S476.
• Jones C, Sachdeva A, Murphy L, Murray M, Brown L, McCloskey E, Atard G, Parmar M, James N, Sydes M , Clarke N et al (2024) #30. Fractures in metastatic hormone-sensitive prostate cancer (mHSPC). Results from two phase 3 trials from the STAMPEDE platform. Journal of Bone Oncology, 45, 100568-100568.
• Brown J, Paggiosi M, Rathbone E, Dodwell D, Cameron D, Gregory W, Eastell R & Coleman R (2024) BoHFAB. The impact of adjuvant zoledronate therapy on bone health in postmenopausal patients with early breast cancer. Journal of Bone Oncology, 45, 100529-100529.
• Wood SL, Lopez-Guajardo A, Oliva M, Collins M, Clézardin P, Croset M & Brown JE (2024) #32. Identification of proteins regulating the metastatic spread of breast cancer to bone: Proteomic analysis of the role of the pro-metastatic transcription factor TWIST1 and the gene target micro-RNA (miR-10b). Journal of Bone Oncology, 45, 100570-100570.
• Wood SL, Lopez-Guajardo A, Oliva MR, Collins M, Pham K, Dunning M, Chambers EV & Brown JE (2024) #28. Identification of key proteins within prostate cancer derived exosomes and their role in priming the pre-metastatic niche. Journal of Bone Oncology, 45, 100566-100566.
• Bittner N, Shi C, Zhao D, Ding J, Southam L, Swift D, Kreitmaier P, Tutino M, Hankinson J, Wilkinson M , Orozco G et al (2024) PRIMARY OSTEOARTHRITIS CHONDROCYTE MAP OF CHROMATIN CONFORMATION REVEALS NOVEL PUTATIVE EFFECTOR GENES. Osteoarthritis and Cartilage, 32, S467-S468.
• Johansson H, Pandey D, Lorentzon M, Harvey NC, McCloskey EV & Kanis JA (2023) A surrogate FRAX model for Nepal. Archives of Osteoporosis, 19(1), S269-S269.
• Petruk N, Wood SL, Gregory W, Lopez-Guajardo A, Oliva M, Mella M, Sandholm J, Jukkola A, Brown JE & Selander KS () Increased primary breast tumor expression of CD73 is associated with development of bone metastases and is a potential biomarker for adjuvant bisphosphonate use. Scientific Reports, 15(1).
• Groeneweg S, van Geest FS, Martín M, Dias M, Frazer J, Medina-Gomez C, Sterenborg RBTM, Wang H, Dolcetta-Capuzzo A, de Rooij LJ , Teumer A et al () Mapping variants in thyroid hormone transporter MCT8 to disease severity by genomic, phenotypic, functional, structural and deep learning integration. Nature Communications, 16(1).
• Vilaca T, Gossiel F, Delaney S, Baker D, Keigwin S, Eastell R & Balasubramanian M () Family mapping of previously identified patients with pathogenic or likely pathogenic ALPL variants using predictive genotyping and detailed phenotyping approach: the FAME case–control study. JBMR Plus.
• Armutcu F & McCloskey E () Fracture Risk Assessment in Metabolic Syndrome in Terms of Secondary Osteoporosis Potential. A Narrative Review. Calcified Tissue International, 116(1).
• Fuggle N, Laslop A, Rizzoli R, Al-Daghri N, Alokail M, Balkowiec-Iskra E, Beaudart C, Bruyère O, Bemden AB-V, Burlet N , Cavalier E et al () Treatment of Osteoporosis and Osteoarthritis in the Oldest Old. Drugs.
• Farhan-Alanie MM, Gallacher D, Craig P, Griffin J, Kozdryk J, Mason J, Wall PDH, Wilkinson JM, Metcalfe A & Foguet P () The Effects of Computer Navigation and Patient-Specific Instrumentation on Risk of Revision, PROMs, and Mortality Following Primary TKR. Journal of Bone and Joint Surgery.
• Kanis JA, Johansson H, McCloskey EV, Liu E, Schini M, Vandenput L, Åkesson KE, Anderson FA, Azagra R, Bager CL , Beaudart C et al () Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX. Osteoporosis International.
• Leigh J, Lee SF, Fawaz A, Jia J, Theriau CF, Rodrigues J, Brown J & Ng TL () Assessment of the benefits of bone modifying agents in the management of advanced breast, prostate, and lung cancers. Current Opinion in Supportive & Palliative Care.
• Tseranidou S, Segarra-Queralt M, Chemorion FK, Le Maitre CL, Piñero J & Noailly J () Nucleus pulposus cell network modelling in the intervertebral disc. npj Systems Biology and Applications, 11(1).
• Lamb JN, West RM, Relton SD, Wilkinson JM & Pandit HG () The Risk of Postoperative Periprosthetic Femoral Fracture After Total Hip Arthroplasty Depends More on Stem Design Than Cement Use. Journal of Bone and Joint Surgery.
• Jeanne M, Ronce N, Remizé S, Arpin S, Baujat G, Breton S, Petit F, Vanlerberghe C, Coeslier-Dieux A, Manouvrier-Hanu S , Vincent-Delorme C et al () Aarskog-Scott syndrome: a clinical study based on a large series of 111 male patients with a pathogenic variant inFGD1and management recommendations. Journal of Medical Genetics.
• Khanna G & Offiah AC () A recap of 2024 and plans for the upcoming year. Pediatric Radiology.
• Kanis JA, Johansson H, Lorentzon M, Harvey NC & McCloskey EV () Conflating the Operational Definition of Osteoporosis with Intervention Thresholds. Calcified Tissue International, 116(1).
• Offiah AC () An introduction to Pediatric Radiology’s new section editors (Outside the Americas). Pediatric Radiology.
• Curtis EM, Miguel M, McEvoy C, Ticinesi A, Torre C, Al-Daghri N, Alokail M, Bałkowiec-Iskra E, Bruyère O, Burlet N , Cavalier E et al () Impact of dementia and mild cognitive impairment on bone health in older people. Aging Clinical and Experimental Research, 37(1).
• Cavalier E, Pikner R, Vasikaran SD, Bhattoa HP, Makris K, McCloskey EV, Harvey NC, Jørgensen NR & Lombardi G () Standardization of the nomenclature of bone status indices: a milestone in diagnostic consistency and clarity. Osteoporosis International.
• Schini M, Lui L-Y, Vilaca T, Ewing SK, Thompson A, Bauer DC, Bouxsein ML, Black DM & Eastell R () The relationship between baseline BMD and fracture incidence in the placebo groups of RCTs using individual patient data from the FNIH-ASBMR-SABRE Project. Journal of Bone and Mineral Research.
• Shieh A, Karlamangla AS, Gossiel F, Eastell R, Burnett-Bowie S-A & Greendale GA () Estimating net bone formation relative to resorption using reference bone turnover markers. The Journal of Clinical Endocrinology & Metabolism.
• Ye C, Morin SN, Lix LM, McCloskey EV, Johansson H, Harvey NC, Kanis JA & Leslie WD () Age at First Fracture and Later Fracture Risk in Older Adults Undergoing Osteoporosis Assessment. JAMA Network Open, 7(12), e2448208-e2448208.
• Lombardi G, Jørgensen NR, Harvey NC, McCloskey EV, Åkesson KE, Eastell R, Garnero P, Kanis JA, Khashayar P, Lane NE , McClung MR et al () Guidelines for the correct use of the nomenclature of biochemical indices of bone status: a position statement of the Joint IOF Working Group and IFCC Committee on Bone Metabolism. Clinical Chemistry and Laboratory Medicine (CCLM).
• Snuggs JW, Senter RK, Whitt JP, Jackson JD & Le Maitre CL () PCRX-201, a novel IL-1Ra gene therapy treatment approach for low back pain resulting from intervertebral disc degeneration. Gene Therapy.
• Dimitri P & Roth CL () Treatment of hypothalamic obesity with GLP-1 analogs. Journal of the Endocrine Society.
• Sengokmen-Ozsoz N, Aleemardani M, Palanca M, Hann A, Reilly G, Dall'Ara E & Claeyssens F () Fabrication of hierarchically porous trabecular bone replicas via 3D printing with high internal phase emulsions (HIPEs). Biofabrication.
• Moraiti S, Cheong VS, Dall’Ara E, Kadirkamanathan V & Bhattacharya P () A novel framework for elucidating the effect of mechanical loading on the geometry of ovariectomized mouse tibiae using principal component analysis. Frontiers in Bioengineering and Biotechnology, 12.
• Schini M, Gossiel F, Saini T, Banda P, Ward R, Vilaca T, Eastell R & Fontalis A () The effects of denosumab on osteoclast precursors in postmenopausal women: a possible explanation for the overshoot phenomenon after discontinuation. Journal of Bone and Mineral Research.
• Harrop R, Blount DG, Khan N, Soyombo M, Moyce L, Drayson MT, Down J, Lawson MA, O’Connor D, Nimmo R , Lad Y et al () Targeting the Tumour Antigen 5T4 using CAR-T Cells for the Treatment of Acute Myeloid Leukaemia. Molecular Cancer Therapeutics.
• Borgström F, Lorentzon M, Johansson H, Harvey NC, McCloskey E, Willems D, Knutsson D & Kanis JA () Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK. Osteoporosis International.
• Lin Z, Dall’Ara E & Guo L () A novel mean shape based post-processing method for enhancing deep learning lower-limb muscle segmentation accuracy. PLOS ONE, 19(10), e0308664-e0308664.
• Ye C, Leslie WD, Al-Azazi S, Yan L, Lix LM, Czaykowski P, McCloskey EV, Johansson H, Harvey NC, Kanis JA & Singh H () Fracture Risk Prediction Using the Fracture Risk Assessment Tool in Individuals With Cancer. JAMA Oncology.
• Lamb JN, Evans JT, Relton S, Whitehouse MR, Wilkinson JM & Pandit H () The incidence of postoperative periprosthetic femoral fracture following total hip replacement: An analysis of UK National Joint Registry and Hospital Episodes statistics data. PLOS Medicine, 21(10), e1004462-e1004462.
• Berg K, Dockrell D, Colvin L, Fraser WD, Tang JCY, Aspray T, Dennison E, Divyateja H, Ghouri N, Hanison E , Keen R et al () Causes of Musculoskeletal Pain in Paget’s Disease of Bone. Calcified Tissue International.
• Gostage J, Kostenuik P, Goljanek-Whysall K, Bellantuono I, McCloskey E & Bonnet N () Extra-osseous Roles of the RANK-RANKL-OPG Axis with a Focus on Skeletal Muscle. Current Osteoporosis Reports.
• Bermudez-Lekerika P, Crump KB, Wuertz-Kozak K, Le Maitre CL & Gantenbein B () Correction: Bermudez-Lekerika et al. Sulfated Hydrogels as Primary Intervertebral Disc Cell Culture Systems. Gels 2024, 10, 330. Gels, 10(10), 612-612.
• McKay C, Abid N, Bishop N, Arundel P & McGinn M () 16 Years of learning: the first patient treated with asfotase alfa for perinatal hypophosphatasia. Endocrine Abstracts.
• Armutcu F & McCloskey E () Insulin resistance, bone health, and fracture risk. Osteoporosis International.
• Langdahl B, Chung Y-S, Plebanski R, Czerwinski E, Dokoupilova E, Supronik J, Rosa J, Mydlak A, Rowińska-Osuch A, Baek K-H , Urboniene A et al () Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12. The Journal of Clinical Endocrinology & Metabolism.
• Lawrence SR & Shah KM () Prospects and Current Challenges of Extracellular Vesicle-Based Biomarkers in Cancer. Biology, 13(9), 694-694.
• Bowles SD, Jacques R, Hill TR, Eastell R & Walsh JS () Effects of High Dose Bolus Cholecalciferol on Free Vitamin D Metabolites, Bone Turnover Markers and Physical Function. Nutrients, 16(17), 2888-2888.
• Cheung MS-M, Cocca A, Harvey CH, Brett CSS, Offiah AC, Borg S, Jenko N, D’Arco F & Thompson D () Natural history of spinal cord compression stage AFMS3 in infants with achondroplasia: retrospective cohort study. Archives of Disease in Childhood.
• O’Regan RM, Zhang Y, Fleming GF, Francis PA, Kammler R, Viale G, Dell’Orto P, Lang I, Bellet M, Bonnefoi HR , Tondini C et al () Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer. JAMA Oncology.
• Huang Q, Mitchell C, Theodoulou E, Lee ACK & Brown J () Implementation of fracture risk assessment in men with prostate cancer requiring long-term androgen deprivation therapy: a systematic scoping review using the i-PARIHS implementation framework. Journal of Cancer Survivorship.
• Court RJ, Swallow V, El-Yousfi S, Gray-Burrows K, Sotir F, Wheeler G, Kellar I, Lee JM, Mitchell R, Mlynarczyk W , Ramavath A et al () Children and young people’s preferences and needs when using health technology to self-manage a long-term condition: a scoping review. Archives of Disease in Childhood.
• Green O, Raju SA, Shiha MG, Nandi N, Bayley M, McCloskey E & Sanders DS () Clinical utility of the fracture risk assessment tool (FRAX) in biopsy-confirmed coeliac disease. Scandinavian Journal of Gastroenterology, 1-6.
• Vilaca T, Schini M, Lui L-Y, Ewing SK, Thompson AR, Vittinghoff E, Bauer DC, Eastell R, Black DM & Bouxsein ML () The relationship between treatment-related changes in total hip bone mineral density measured after 12, 18 and 24 months and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE Project. Journal of Bone and Mineral Research.
• Collinson F, Royle K-L, Swain J, Ralph C, Maraveyas A, Eisen T, Nathan P, Jones R, Meads D, Min Wah T , Martin A et al () Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT. Health Technology Assessment, 1-171.
• Cosman F, Lewiecki EM, Eastell R, Ebeling PR, De Beur SJ, Langdahl B, Rhee Y, Fuleihan GE-H, Kiel DP, Schousboe JT , Borges JL et al () Goal-Directed Osteoporosis Treatment: ASBMR/BHOF Task Force Position Statement 2024. Journal of Bone and Mineral Research.
• Kowo-Nyakoko F, Gregson CL, Westbury LD, Madanhire T, Offiah AC, Micklesfield LK, Ferrand RA, Rehman AM & Ward KA () The impact of HIV infection on skeletal maturity in peripubertal children in Zimbabwe: a cross-sectional study. BMC Pediatrics, 24(1).
• Culliford R, Lawrence SED, Mills C, Tippu Z, Chubb D, Cornish AJ, Browning L, Kinnersley B, Bentham R, Sud A , Pallikonda H et al () Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. Nature Communications, 15(1).
• Evans H, Andrews R, Abedi FA, Sprules A, Trend J, Lovric G, Green A, Chantry A, Clarkin C, Brown J & Lawson M () Evidence for peri-lacunar remodeling and altered osteocyte lacuno-canalicular network in mouse models of myeloma-induced bone disease. JBMR Plus.
• Kanis JA, Harvey NC, Lorentzon M, Liu E, Schini M, Abrahamsen B, Adachi JD, Alokail M, Borgstrom F, Bruyère O , Carey JJ et al () Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk. Osteoporosis International.
• Tamblin-Hopper P, Kiss-Toth E, Sudbery I, Young D & Wilkinson JM () The potential therapeutic applications of long non-coding RNAs. Journal of Translational Genetics and Genomics, 8(2), 225-43.
• Kanis JA, Dawson-Hughes B, Campusano C, Cooper C, Ebeling PR, Halbout P, Harvey NC, McCloskey EV, McClung MR, Reginster J-Y , Saleh Y et al () IOF position on scientists and societies operating in conflict zones. Osteoporosis International.
• Westbury LD, Harvey NC, Beaudart C, Bruyère O, Cauley JA, Cawthon P, Cruz-Jentoft AJ, Curtis EM, Ensrud K, Fielding RA , Johansson H et al () Predictive value of sarcopenia components for all-cause mortality: findings from population-based cohorts. Aging Clinical and Experimental Research, 36(1).
• McCloskey E, Tan ATH & Schini M () Update on fracture risk assessment in osteoporosis. Current Opinion in Endocrinology, Diabetes & Obesity.
• Leta TH, Lie SA, Fenstad AM, Lygre SHL, Lindberg-Larsen M, Pedersen AB, W-Dahl A, Rolfson O, Bülow E, van Steenbergen LN , Nelissen RGHH et al () Periprosthetic Joint Infection After Total Knee Arthroplasty With or Without Antibiotic Bone Cement. JAMA Network Open, 7(5), e2412898-e2412898.
• Bermudez-Lekerika P, Crump KB, Wuertz-Kozak K, Le Maitre CL & Gantenbein B () Sulfated Hydrogels as Primary Intervertebral Disc Cell Culture Systems. Gels, 10(5), 330-330.
• Schini M, Vilaca T, Lui L-Y, Ewing SK, Thompson A, Vittinghoff E, Bauer DC, Bouxsein ML, Black DM & Eastell R () Pre-treatment bone mineral density (BMD) and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project. Journal of Bone and Mineral Research.
• O'Neill K, O'Dell C & Nobody A () Test 4. Nature Conservation.
• Chakraborty LS, Le Maitre CL, Chahine NO, Fields AJ, Gawri R, Giers MB, Smith LJ, Tang SY, Zehra U, Haglund L , Samartzis D et al () Impact of the COVID‐19 pandemic on the productivity and career prospects of musculoskeletal researchers. Journal of Orthopaedic Research.
• McNaught E, Reale S, Bourke L, Brown JE, Collinson M, Day F, Hewison J, Farrin AJ, Ibeggazene S, Innes AQ , Mason E et al () Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation. Trials, 25(1).
• Horner DE, Davis S, Pandor A, Shulver H, Goodacre S, Hind D, Rex S, Gillett M, Bursnall M, Griffin X , Holland M et al () Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis. Health Technology Assessment, 1-166.
• Sahota O, Narayanasamy M, Bastounis A, Paskins Z, Bishop S, Langley T, Gittoes N, Davis S, Baily A, Holmes M & Leonardi-Bee J () Bisphosphonate alternative regimens for the prevention of osteoporotic fragility fractures: BLAST-OFF, a mixed-methods study. Health Technology Assessment, 1-169.

Chapters

• Wood S, Arikrishnan A, D’Oronzo S & Brown J (2025) Bone metastases; clinical aspects, Reference Module in Biomedical Sciences Elsevier
• Maikore F, Mazumdar S, Offiah A, Hughes A, Roychowdhury S, Hocking K & Lanfranchi V (2025) Understanding Inflicted Injuries in Young Children: Toward an Ontology Based Approach, Lecture Notes in Computer Science (pp. 260-270). Springer Nature Switzerland
• Henry YM & Eastell R (2024) Biochemical markers of bone turnover: age, gender and race as sources of biological variability, Bone Markers (pp. 95-106). CRC Press
• Greenfield DM, Hannon RA & Eastell R (2024) The association between bone turnover and fracture risk (Sheffield Osteoporosis Study), Bone Markers (pp. 225-236). CRC Press

Other

• Harrop R, Blount DG, Khan N, Soyombo M, Moyce L, Drayson MT, Down J, Lawson MA, O’Connor D, Nimmo R , Lad Y et al (2025) Supplementary Figure 2 from Targeting Tumor Antigen 5T4 Using CAR T Cells for the Treatment of Acute Myeloid Leukemia.
• Harrop R, Blount DG, Khan N, Soyombo M, Moyce L, Drayson MT, Down J, Lawson MA, O’Connor D, Nimmo R , Lad Y et al (2025) Supplementary Table 2 from Targeting Tumor Antigen 5T4 Using CAR T Cells for the Treatment of Acute Myeloid Leukemia.
• Harrop R, Blount DG, Khan N, Soyombo M, Moyce L, Drayson MT, Down J, Lawson MA, O’Connor D, Nimmo R , Lad Y et al (2025) Data from Targeting Tumor Antigen 5T4 Using CAR T Cells for the Treatment of Acute Myeloid Leukemia.
• Harrop R, Blount DG, Khan N, Soyombo M, Moyce L, Drayson MT, Down J, Lawson MA, O’Connor D, Nimmo R , Lad Y et al (2025) Supplementary Figure 3 from Targeting Tumor Antigen 5T4 Using CAR T Cells for the Treatment of Acute Myeloid Leukemia.
• Harrop R, Blount DG, Khan N, Soyombo M, Moyce L, Drayson MT, Down J, Lawson MA, O’Connor D, Nimmo R , Lad Y et al (2025) Supplementary Table 1 from Targeting Tumor Antigen 5T4 Using CAR T Cells for the Treatment of Acute Myeloid Leukemia.
• Harrop R, Blount DG, Khan N, Soyombo M, Moyce L, Drayson MT, Down J, Lawson MA, O’Connor D, Nimmo R , Lad Y et al (2025) Supplementary Figure 1 from Targeting Tumor Antigen 5T4 Using CAR T Cells for the Treatment of Acute Myeloid Leukemia.
• Harrop R, Blount DG, Khan N, Soyombo M, Moyce L, Drayson MT, Down J, Lawson MA, O’Connor D, Nimmo R , Lad Y et al (2025) Supplementary Figure 4 from Targeting Tumor Antigen 5T4 Using CAR T Cells for the Treatment of Acute Myeloid Leukemia.

Preprints

• Katsoula G, Arruda AL, Tutino M, Kreitmaier P, Shah KM, Swift D, Southam L, Wilkinson JM & Zeggini E (2024) Transcriptome regulation analysis in osteoarthritis primary tissues identifies high-confidence effector genes, Cold Spring Harbor Laboratory.
• Tseranidou S, Segarra-Queralt M, Chemorion FK, Le Maitre C, Piñero J & Noailly J (2024) Nucleus Pulposus Cell Network Modelling in the Intervertebral Disc, Cold Spring Harbor Laboratory.
• Low KJ, Foreman J, Hobson RJ, Kwuo H, Martinez-Cayuelas E, Almoguera B, Marin-Reina P, Caraffi SG, Garavelli L, Woods E , Balasubramanian M et al (2024) The LMSz method - an automatable scalable approach to constructing gene-specific growth charts in rare disorders, Cold Spring Harbor Laboratory.
• Webber K, Patel S, Kizer JR, Eastell R, Psaty BM, Newman AB & Cummings SR (2024) Associations of Serum GDF-15 Levels with Physical Performance, Mobility Disability, Cognition, Cardiovascular Disease, and Mortality in Older Adults, Cold Spring Harbor Laboratory.
• Avgoustou P, Jailani ABA, Desai AJ, Roberts DJ, Lilley E, Stothard G, Richards GO & Skerry TM (2024) Receptor activity modifying protein modulation of parathyroid hormone-1 receptor function and signalling, Cold Spring Harbor Laboratory.
• Al-janabi H, Moyes K, Allen R, Fisher M, Crespo M, Gurel B, Rescigno P, De Bono J, Nunns H, Bailey C , Juncker-Jensen A et al (2024) Targeting of a STING Agonist to Perivascular Macrophages in Prostate Tumors Delays Resistance to Androgen Deprivation Therapy, Cold Spring Harbor Laboratory.